{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:06:17Z","timestamp":1790201177485,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.toxicon.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T13:06:33Z","timestamp":1408107993000},"page":"344-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-531X","authenticated-orcid":false,"given":"Juan","family":"Ramirez-Castaneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.toxicon.2014.07.009_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ceo.12165","article-title":"Long-term efficacy and safety of botulinum toxin a injections to treat blepharospasm and hemifacial spasm","volume":"42","author":"Ababneh","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.toxicon.2014.07.009_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12640-009-9023-3","article-title":"Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs","volume":"15","author":"Bentivoglio","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2014.07.009_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mds.20290","article-title":"Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia","volume":"20","author":"Berman","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1531-8257(200001)15:1<150::AID-MDS1024>3.0.CO;2-X","article-title":"Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A","volume":"15","author":"Brashear","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/eye.2009.192","article-title":"Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes","volume":"24","author":"Cillino","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.toxicon.2014.07.009_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12640-012-9314-y","article-title":"Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review","volume":"22","author":"Colosimo","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2014.07.009_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajo.2013.02.001","article-title":"Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome","volume":"156","author":"Czyz","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.toxicon.2014.07.009_bib8","first-page":"6567","article-title":"Botulinum toxin treatment of patients with oromandibular dystonia","volume":"162","author":"Erdal","year":"2000","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.toxicon.2014.07.009_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2014.07.009_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/WNL.50.6.1624","article-title":"Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response","volume":"50","author":"Hanna","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2014.07.009_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10659","article-title":"Long-term follow-up of cervical dystonia patients treated with botulinum toxin A","volume":"19","author":"Haussermann","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period","volume":"17","author":"Hsiung","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2014.07.009_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03033933","article-title":"Botulinum toxin therapy for cervical dystonia","volume":"9","author":"Jankovic","year":"2006","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.toxicon.2014.07.009_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.25552","article-title":"Medical treatment of dystonia","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2014.07.009_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group","volume":"246","author":"Kessler","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2014.07.009_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/mds.23681","article-title":"Botulinum toxin injections reduce associative plasticity in patients with primary dystonia","volume":"26","author":"Kojovic","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.23504","article-title":"Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more","volume":"26","author":"Lungu","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","article-title":"Long-term botulinum toxin efficacy, safety, and immunogenicity","volume":"20","author":"Mejia","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2014.07.009_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/174313209X405137","article-title":"A long-term follow-up of botulinum toxin A in cervical dystonia","volume":"31","author":"Mohammadi","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.toxicon.2014.07.009_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/toxins5020249","article-title":"Long-term efficacy and safety of botulinum toxin injections in dystonia","volume":"5","author":"Ramirez-Castaneda","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2014.07.009_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/01.WNL.0000149768.36634.92","article-title":"Botulinum toxin injections in the treatment of musician's dystonia","volume":"64","author":"Schuele","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2014.07.009_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","article-title":"The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment","volume":"12","author":"Skogseid","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2014.07.009_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9394(03)00075-8","article-title":"Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm","volume":"136","author":"Snir","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.toxicon.2014.07.009_bib26","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/WNL.53.9.2102","article-title":"Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up","volume":"53","author":"Tan","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.toxicon.2014.07.009_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","article-title":"Treatment of dystonia","volume":"11","author":"Thenganatt","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.toxicon.2014.07.009_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010114002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010114002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T11:53:35Z","timestamp":1538308415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010114002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":28,"alternative-id":["S0041010114002050"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2014.07.009","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}